Drug-Coated Balloons for the Treatment of Coronary Artery Disease: A Review.
Camaj A, Leone PP, Colombo A, Vinayak M, Stone GW, Mehran R, Dangas G, Kini A, Sharma SK.
JAMA Cardiol. 2025 Feb 1;10(2):189-198. doi: 10.1001/jamacardio.2024.4244.
Drug-coated balloon for the management of coronary chronic total occlusions.
Sanchez-Jimenez E, El-Mokdad R, Chaddad R, Cortese B.
Rev Cardiovasc Med. 2022 Jan 24;23(2):42. doi: 10.31083/j.rcm2302042.
Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.
Lancet. 2016 Nov 26;388(10060):2618-2628. doi: 10.1016/S0140-6736(16)31922-5. Epub 2016 Oct 30.
Retrograde balloon hemostasis.
Ungureanu C, Leone PP, Colletti G, Gasparini GL.
Catheter Cardiovasc Interv. 2023 Nov;102(5):896-899. doi: 10.1002/ccd.30822. Epub 2023 Sep 25.
Drug-coated balloons for coronary artery disease: current concepts and controversies.
Buccheri D, Lombardo RM, Cortese B.
Future Cardiol. 2019 Nov;15(6):437-454. doi: 10.2217/fca-2019-0009. Epub 2019 Nov 5.
Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation.
Hong SJ, Kim H, Ahn CM, Kim JS, Kim BK, Ko YG, Hong BK, Choi D, Jang Y, Hong MK.
Yonsei Med J. 2019 Sep;60(9):824-831. doi: 10.3349/ymj.2019.60.9.824.
Insights into stent implantation for coronary artery lesions caused by Kawasaki disease.
Tsuda E.
Cardiol Young. 2020 Jul;30(7):911-918. doi: 10.1017/S104795112000133X. Epub 2020 Jun 9.
Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon.
Zhang Y, Zhang X, Dong Q, Chen D, Xu Y, Jiang J.
Front Cardiovasc Med. 2021 Dec 1;8:762391. doi: 10.3389/fcvm.2021.762391. eCollection 2021.
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion.
Zhang Y, Wu Z, Wang S, Liu T, Liu J.
Cardiovasc Drugs Ther. 2023 Dec;37(6):1155-1166. doi: 10.1007/s10557-022-07363-7. Epub 2022 Aug 5.
Feasibility of use of magnesium reabsorbable scaffolds in complex coronary artery disease: True bifurcation, multiple overlapping scaffolds and chronic total occlusion treatment.
Bayón J, Santá-Álvarez M, Ocaranza-Sánchez R, González-Juanatey C.
Rev Port Cardiol (Engl Ed). 2018 Dec;37(12):1009.e1-1009.e3. doi: 10.1016/j.repc.2017.08.013. Epub 2018 Dec 13.
